Terms: = Liver cancer AND PAX8, ENSG00000125618, 7849 AND Diagnosis
16 results:
1. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
2. liver Mass as First-Time diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
4. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
5. Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.
Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
[TBL] [Abstract] [Full Text] [Related]
6. Malignant testicular unclassified sex cord stromal tumor: a case report.
Morinaga S; Aoki S; Tsuzuki T; Kanematsu K; Kawai N; Sato S; Nakamizu K; Goto K; Niwa M; Nomura I; Sawada T; Futamachi R; Morita F; Yamada Y
J Med Case Rep; 2022 Nov; 16(1):406. PubMed ID: 36335378
[TBL] [Abstract] [Full Text] [Related]
7. Mesenteric and Retroperitoneal Mucinous Cystic Neoplasms: A Case Series.
Van Treeck BJ; Horton RK; Lee HE; Rosty C; Pai RK; Graham RP
Int J Surg Pathol; 2021 Sep; 29(6):606-614. PubMed ID: 33736504
[No Abstract] [Full Text] [Related]
8. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
10. Resection for Primary Retroperitoneal Serous Adenocarcinoma and liver Metastasis.
Nakatake R; Ishizaki M; Ishida M; Matsui K; Kawaguchi Y; Kaibori M
Intern Med; 2018 Dec; 57(23):3371-3375. PubMed ID: 30101904
[TBL] [Abstract] [Full Text] [Related]
11. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic chromophobe renal cell carcinoma to the brain.
Prayson RA
J Clin Neurosci; 2016 Apr; 26():152-3. PubMed ID: 26589090
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic renal cell carcinoma without evidence of a renal primary.
Costantino C; Thomas GV; Ryan C; Coakley FV; Troxell ML
Int Urol Nephrol; 2016 Jan; 48(1):73-7. PubMed ID: 26527083
[TBL] [Abstract] [Full Text] [Related]
14. Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature.
Zhang W; Wang Q; Jiang YX; Lu Q; Yu WJ; Liu Y; Liu YL; Zhao H; Zhuang J; Li YJ
Int J Clin Exp Pathol; 2015; 8(1):995-9. PubMed ID: 25755808
[TBL] [Abstract] [Full Text] [Related]
15. Newly available antibodies with practical applications in surgical pathology.
Chan JK
Int J Surg Pathol; 2013 Dec; 21(6):553-72. PubMed ID: 24225578
[TBL] [Abstract] [Full Text] [Related]
16. pax8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with b cells and tumors of pancreatic origin.
Tacha D; Qi W; Zhou D; Bremer R; Cheng L
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):59-63. PubMed ID: 22595948
[TBL] [Abstract] [Full Text] [Related]